Navigation Links
Mesa Labs Reports Record Year End Sales and Earnings
Date:5/19/2008

LAKEWOOD, Colo., May 19 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) today reported record sales and net income results for the year ended March 31, 2008.

Highlights:

-- Annual revenue increases 13% to a new record

-- Annual operating income increases 25% to a new record

-- Annual net income increases 16% to a new record

-- Fourth quarter revenue increases 10% to a new record

-- Fourth quarter operating income increases 7% to a new record

Net sales for the fiscal year ended March 31, 2008 increased 13 percent to a record $19,558,000 compared to $17,242,000 in the same period last year. Operating income for the year increased 25 percent to $7,061,000 compared to $5,659,000, while net income for the year increased 16 percent to a record $4,610,000 or $1.41 per diluted share compared to $3,958,000 or $1.22 per diluted share one year ago.

For the fourth quarter of fiscal 2008, net sales were up 10 percent to a record $5,790,000 compared to $5,286,000 in the same quarter last year. Operating income for the quarter increased seven percent to $1,937,000 compared to $1,805,000, while net income for the quarter decreased 17 percent to $1,195,000 or $.36 per diluted share compared to $1,438,000 or $.44 per diluted share one year ago, caused by tax adjustments in the fourth quarter of fiscal 2007.

For the fiscal year, Mesa experienced net income growth of 16 percent, which was ahead of the sales growth rate of 13 percent. Most of this acceleration of profitability for the fiscal year can be attributed to a gain in gross profits as a percent of net sales. During the fiscal fourth quarter, we saw a 17 percent decline in net income despite a year over year increase in
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. BMP Sunstone Reports First Quarter 2008 Financial Results
2. Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008
3. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
4. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
5. China Yingxia International, Inc. Reports First Quarter 2008 Results
6. Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008
7. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
8. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
9. Nephros Reports 2008 First Quarter Financial Results
10. PreMD Reports First Quarter Results
11. Lifeway Foods Reports Record 1st Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...YHILL,N.J.,Nov.23/PRNewswire/--InasurveyofNewJerse...hiefFinancialOfficers,72percentdonotbelieveanewhea...tem. ,, Accordingtoresultsofthelatestsurveycond...untingfirm,theeconomytoppedthelistat85percentasthe...sestoits1500surveyssenttocompaniesfromallpartsofNe...
(Date:11/23/2009)...J. The Center for Science Writings at Stevens Ins...f God," a talk by Robert Wright, journalist and fo...09, 4:00-5:30 p.m. at the Babbio Center for Techno...pen to the public and the media., In his new boo...st Robert Wright, renowned for his popular works o...
(Date:11/23/2009)...Minn. -- Major medical errors self-reported by Ame...t and depression. Those findings appear today in t... Clinic-led study included collaborators from John..., In the confidential study, nearly 9 percent o...error in the three months prior to being surveyed....
(Date:11/23/2009)...N, Va. The Infectious Diseases Society of America...administration and the European Union to further t... 10 new antibiotics within the next 10 years, know...ganization (WHO) has identified antimicrobial resi...an health. , A new European Union report confirm...
(Date:11/23/2009)...in home-based settings get far more screen time t... , MONDAY, Nov. 23 (HealthDay News) --Young c...evision every day than previous reports have found... a new study finds. , Researchers from Seattle ...on surveyed day-care directors to find out how muc...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3
...iefu, vice minister of health in China has sought ... demand of organs by patients in their country//. ...ed for organ donations and the actual donations. ...onated by people after signing voluntary agreement...
...ng to a research conducted by Dr Michael Kisley, a...he US, older people have a more positive// outlook...e reported in the journal Psychological Science. ...ative aspects of life. The viewing was restricted ...
...nation of AZT, lamivudine, and nevirapine (AZT/3TC...e month after delivery resulted in significantly r...the HIV levels found in the breast milk of women w...s pilot study to examine the effect of using tripl...
...utes, perversions and public scandals – the stuff ...rs three centuries earlier,// according to new res...ing of erotic literature was already a social acti...tury Britain: "I tried to get a grip on just how m...
... has been declared free of neonatal tetanus by the... Kartar Devi said Saturday that a communication ha... welfare ministry, declaring that neonatal tetanus... a survey conducted by the central ministry on bir...
...s with arterial disease have relatively high rates...eart attack, stroke or //cardiovascular death) wit...f arterial locations afflicted, according to a stu...AD; narrowing of the arteries that supply the legs...
Other Medicine News:Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 2Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 3Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 4Health News:Sex – Three Hundred Years Ag 2Health News:Sex – Three Hundred Years Ag 3Health News:Atherothrombosis Associated With High Rates of Cardiovascular Events 2
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.comanno...atalogue. ,, HolterMonitoringSystems-AGlobalMa...164324/Holter-Monitoring-Systems---A-Global-Market...pr&utm_campaign=prnewswire ,, Cardiovas...ents.High-riskpatientsneedtobecontinuouslymonitore...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.comanno...atalogue. ,, AnesthesiaDisposables-AWorldMarke...276/Anesthesia-Disposables---A-World-Market-Review...utm_campaign=prnewswire ,, Globalgeneralane...eeofsaturation.Despitetheconsiderablerisewitnessed...
(Date:11/23/2009)..., BIRMINGHAM,Ala.andNOIDA,India,Nov.23/PRNewswire-...amaatBirmingham(UAB),andSouthernResearchInstitutet...gtheircollectiveinnovationandenablingtechnologiesi...iseases.ItisauniqueU.S.-Indiaarbitragedandleverage...rdabletherapiesforpatientsworldwide.AMemorandumofU...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 1OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 2OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 3Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 1Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 2WellTek MedX Group Completes Major Reorganization 6168 1WellTek MedX Group Completes Major Reorganization 6168 2
...e Francophone du Myelome (IFM),Trial Presented Dur...wire-FirstCall/ --,Millennium Pharmaceuticals, Inc...he comparative Phase III clinical trial evaluating...le myeloma (MM),patients. As induction therapy pri... based therapy produced a high complete remission,...
.../PRNewswire/ -- Portola,Pharmaceuticals, Inc. anno...linical data on its oral Factor Xa inhibitor and o... at the XXI Congress of,the International Society ...itzerland on July 6 through July 12, 2007. , The E...Company,s,lead compound PRT054021, is entitled "Ev...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 2Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 3
GENIE BLOTTER
The Panther Semi-dry Electroblotter - Model HEP-3 (Complete System)
Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell
...inated DNA and RNA from agarose gels to hybridizat...s speed and efficiency of transfer by allowing hig...ated system allowing electrophoresis, gel treatmen...us 29 hours required for conventional methods ,Pos...
Medicine Products: